Fruit and Vegetable Juices and Alzheimer's Disease: The Kame Project

American Journal of Medicine

Volumn 119, Issue 9, 2006, Pages 751-759

  Dai, Qi ^a   Borenstein, Amy R ^b   Wu, Yougui ^b   Jackson, James C ^c,d,e   Larson, Eric B ^f  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d Pulmonary   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f CENTER FOR HEALTH STUDIES   (United States)

Author keywords

Alzheimer's disease; Antioxidants; Epidemiology; Fruit and vegetable juices; Polyphenols

Indexed keywords

ALPHA TOCOPHEROL; APOLIPOPROTEIN E; ASCORBIC ACID; BETA CAROTENE; POLYPHENOL DERIVATIVE;

ADULT; ALZHEIMER DISEASE; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMENTIA; FEMALE; FOLLOW UP; FOOD INTAKE; FRUIT; HAZARD ASSESSMENT; HUMAN; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; TEA; TIME SERIES ANALYSIS; VEGETABLE;

AGED; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; BEVERAGES; COHORT STUDIES; DATA COLLECTION; FEMALE; FLAVONOIDS; FRUIT; HUMANS; INCIDENCE; JAPAN; MALE; PHENOLS; QUESTIONNAIRES; RISK FACTORS; VEGETABLES; WASHINGTON;

EID: 33747878212     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.03.045     Document Type: Article

References (74)

1. Butterfield D.A., Drake J., Pocernich C., and Castegna A. Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol Med 7 12 (2001) 548-554
2. Honda K., Casadesus G., Petersen R.B., Perry G., and Smith M.A. Oxidative stress and redox-active iron in Alzheimer's disease. Ann N Y Acad Sci 1012 (2004) 179-182
3. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23 1 (1997) 134-147
4. Petersen R.C., Thomas R.G., Grundman M., et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med 352 23 (2005) 2379-2388
5. Luchsinger J.A., Tang M.X., Shea S., and Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 60 2 (2003) 203-208
6. Morris M.C., Beckett L.A., Scherr P.A., et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord 12 3 (1998) 121-126
7. Zandi P.P., Anthony J.C., Khachaturian A.S., et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. Arch Neurol 61 1 (2004) 82-88
8. Engelhart M.J., Geerlings M.I., Ruitenberg A., et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 24 (2002) 3223-3229
9. Morris M.C., Evans D.A., Bienias J.L., et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287 24 (2002) 3230-3237
10. Manach C., Scalbert A., Morand C., Remesy C., and Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 79 5 (2004) 727-747
11. Scalbert A., and Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 130 8S Suppl (2000) 2073S-2085S
12. Bates B.P., Morris J.R., and Crandall P.G. Principles and Practices of Small- and Medium- Scale Fruit Processing (2001), Food Science and Human Nutrition Department, University of Florida, Gainesville, FL
13. Bazemore R., Rouseff R., and Naim M. Linalool in orange juice: origin and thermal stability. J Agric Food Chem 51 1 (2003) 196-199
14. Lindsay J., Laurin D., Verreault R., et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156 5 (2002) 445-453
15. Forster D.P., Newens A.J., Kay D.W., and Edwardson J.A. Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Community Health 49 3 (1995) 253-258
16. Rogers M.A., and Simon D.G. A preliminary study of dietary aluminium intake and risk of Alzheimer's disease. Age Ageing 28 2 (1999) 205-209
17. Laurin D., Masaki K.H., Foley D.J., White L.R., and Launer L.J. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 159 10 (2004) 959-967
18. Lugasi A., and Hovari J. Antioxidant properties of commercial alcoholic and nonalcoholic beverages. Nahrung 47 2 (2003) 79-86
19. Manach C., Morand C., Gil-Izquierdo A., Bouteloup-Demange C., and Remesy C. Bioavailability in humans of the flavanones hesperidin and narirutin after the ingestion of two doses of orange juice. Eur J Clin Nutr 57 2 (2003) 235-242
20. Bub A., Watzl B., Blockhaus M., et al. Fruit juice consumption modulates antioxidative status, immune status and DNA damage. J Nutr Biochem 14 2 (2003) 90-98
21. Vinson J.A., Liang X., Proch J., Hontz B.A., Dancel J., and Sandone N. Polyphenol antioxidants in citrus juices: in vitro and in vivo studies relevant to heart disease. Adv Exp Med Biol 505 (2002) 113-122
22. Heo H.J., and Lee C.Y. Protective effects of quercetin and vitamin C against oxidative stress-induced neurodegeneration. J Agric Food Chem 52 (2004) 7514-7517
23. Heo H.J., Kim D.O., Shin S.C., Kim M.J., Kim B.G., and Shin D.H. Effect of antioxidant flavanone, naringenin, from Citrus junoson neuroprotection. J Agric Food Chem 52 6 (2004) 1520-1525
24. Nakayama T., Yamada M., Osawa T., and Kawakishi S. Suppression of active oxygen-induced cytotoxicity by flavonoids. Biochem Pharmacol 45 1 (1993) 265-267
25. Patil C.S., Singh V.P., Satyanarayan P.S., Jain N.K., Singh A., and Kulkarni S.K. Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology 69 2 (2003) 59-67
26. O'Byrne D.J., Devaraj S., Grundy S.M., and Jialal I. Comparison of the antioxidant effects of Concord grape juice flavonoids alpha-tocopherol on markers of oxidative stress in healthy adults. Am J Clin Nutr 76 6 (2002) 1367-1374
27. Graves A.B., Larson E.B., Edland S.D., et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington state. The Kame Project. Am J Epidemiol 144 8 (1996) 760-771
28. Larson E.B., McCurry S.M., and Graves A.B. Standardization of the clinical diagnosis of the dementia syndrome and its subtypes in a cross-national study: the Ni-Hon-Sea experience. J Gerontol 53 (1998) M313-M319
29. Teng E.L., Hasegawa K., Homma A., et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6 1 (1994) 45-58
30. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
31. Morris J.C., Heyman A., Mohs R.C., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 (1989) 1159-1165
32. Welsh K.A., Butters N., Mohs R.C., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology 44 4 (1994) 609-614
33. Kiernan R.J., Mueller J., Langston J.W., and Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med 107 4 (1987) 481-485
34. Reitan R.M., and Wolfson D. The Halstead-Reitan Neuropsychological Test Battery (1985), Neuropsychology Press, Tempe, AZ
35. Shipley W.C. Institute of Living Scale (1946), Western Psychological Services Corp, Los Angeles, CA
36. Tiffin J. Purdue Pegboard: Examiner Manual (1968), Science Research Associates, Chicago, IL
37. Wechsler D. Wechsler Adult Intelligence Scale-Revised (1981), Psychological Corporation, New York
38. Wechsler D. Wechsler Memory Scale-Revised (1987), Psychological Corporation, New York
39. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
40. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
41. Roman G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 2 (1993) 250-260
42. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., and Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 42 3 Pt 1 (1992) 473-480
43. Hankin J.H., and Wilkens L.R. Development and validation of dietary assessment methods for culturally diverse populations. Am J Clin Nutr 59 1 Suppl (1994) 198S-200S
44. Hankin J.H., Nomura A.M., Lee J., Hirohata T., and Kolonel L.N. Reproducibility of a diet history questionnaire in a case-control study of breast cancer. Am J Clin Nutr 37 6 (1983) 981-985
45. Hankin J.H., Wilkens L.R., Kolonel L.N., and Yoshizawa C.N. Validation of a quantitative diet history method in Hawaii. Am J Epidemiol 133 6 (1991) 616-628
46. Hankin J.H. Dietary methods for estimating vitamin A and carotene intakes in epidemiologic studies of cancer. J Can Diet Assoc 47 (1987) 219-224
47. Doty R.L., Marcus A., and Lee W.W. Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 106 3 Pt 1 (1996) 353-356
48. Graves A.B., Bowen J.D., Rajaram L., et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 53 7 (1999) 1480-1487
49. Miller S.A., Dykes D.D., and Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16 3 (1988) 1215
50. Emi M., Wu L.L., Robertson M.A., et al. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 3 4 (1988) 373-379
51. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31 3 (1990) 545-548
52. Hosmer D.W., and Lemeshow S. Applied Survival Analysis. Regression Modeling of Time to Even Data (1999), Wiley, New York
53. Korn E.L., Graubard B.I., and Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145 1 (1997) 72-80
54. Borenstein A.R., Wu Y., Mortimer J.A., et al. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol Aging 26 3 (2005) 325-334
55. Evans D.A., and Morris M.C. Is a randomized trial of antioxidants in the primary prevention of Alzheimer disease warranted?. Alzheimer Dis Assoc Disord 10 Suppl 1 (1996) 45-49
56. Grundman M., Grundman M., and Delaney P. Antioxidant strategies for Alzheimer's disease. Proc Nutr Soc 61 2 (2002) 191-202
57. Orgogozo J.M., Dartigues J.F., Lafont S., et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Revue Neurologique 153 (1997) 185-192
58. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., and Dartigues J.F. Intake of flavonoids and risk of dementia. Eur J Epidemiol 16 4 (2000) 357-363
59. Smith C.D., Carney J.M., Starke-Reed P.E., et al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci U S A 88 23 (1991) 10540-10543
60. Nunomura A., Perry G., Pappolla M.A., et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19 6 (1999) 1959-1964
61. Smith M.A., Hirai K., Hsiao K., et al. Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70 5 (1998) 2212-2215
62. Opazo C., Huang X., Cherny R.A., et al. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem 277 43 (2002) 40302-40308
63. Behl C., Davis J.B., Lesley R., and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77 6 (1994) 817-827
64. Youdim K.A., Qaiser M.Z., Begley D.J., Rice-Evans C.A., and Abbott N.J. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 36 5 (2004) 592-604
65. Ortiz D., and Shea T.B. Apple juice prevents oxidative stress induced by amyloid-beta in culture. J Alzheimers Dis 6 1 (2004) 27-30
66. Nakayama T. Suppression of hydroperoxide-induced cytotoxicity by polyphenols. Cancer Res 54 7 Suppl (1994) 1991s-1993s
67. Ishige K., Schubert D., and Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med 30 4 (2001) 433-446
68. Rogers E.J., Milhalik S., Orthiz D., and Shea T.B. Apple juice prevents oxidative stress and impaired cognitive performance caused by genetic and dietary deficiencies in mice. J Nutr Health Aging 8 2 (2004) 92-97
69. Hodgson J.M., Croft K.D., Mori T.A., Burke V., Beilin L.J., and Puddey I.B. Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 132 1 (2002) 55-58
70. O'Reilly J.D., Mallet A.I., McAnlis G.T., et al. Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73 6 (2001) 1040-1044
71. Sanchez-Moreno C., Cano M.P., de Ancos B., et al. High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J Nutr 133 7 (2003) 2204-2209
72. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., and FitzGerald G.A. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285 9 (2001) 1178-1182
73. Kiefer I., Prock P., Lawrence C., et al. Supplementation with mixed fruit and vegetable juice concentrates increased serum antioxidants and folate in healthy adults. J Am Coll Nutr 23 3 (2004) 205-211
74. Wang H.X., Wahlin A., Basun H., Fastbom J., Winblad B., and Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology 56 9 (2001) 1188-1194